tradingkey.logo
tradingkey.logo
Suchen

Fresenius Medical Care AG

FMS
Zur Watchlist hinzufügen
23.638USD
-0.082-0.34%
Trading geöffnet ETKurse um 15 Minuten verzögert
6.29BMarktkapitalisierung
12.62KGV TTM

mehr Informationen über Fresenius Medical Care AG Unternehmen

Fresenius Medical Care AG, formerly Fresenius Medical Care AG & Co. KGaA is a Germany-based kidney dialysis institute. The Company provides dialysis care and related services to persons suffering from end-stage renal disease (ESRD) and offers other extracorporeal therapies, as well as other healthcare services. It has two operating segments such as care delivery segment which consolidates the global health care services business and care enablement segment includes research and development (R&D), manufacturing, supply chain, and commercial operations. It develops and manufactures health care products, which includes dialysis and non-dialysis products. Such as hemodialysis machines, peritoneal cyclers, dialyzers, peritoneal solutions and granulates, bloodlines, renal pharmaceuticals, and systems for water treatment. Its non-dialysis products include acute cardiopulmonary and apheresis products. It owns, operates, or manages dialysis clinics sells products to other dialysis providers.

Fresenius Medical Care AG Profil

BörsenkürzelFMS
Name des UnternehmensFresenius Medical Care AG
IPO-datumOct 02, 1996
CEOCordola (Craig)
Anzahl der mitarbeiter111513
WertpapierartDepository Receipt
GeschäftsjahresendeOct 02
AddresseElse-Kroener-Strasse 1
StadtBAD HOMBURG VOR DER HOHE
BörseNASDAQ OMX NASDAQ Basic NYSE
LandGermany
Postleitzahl61352
Telefon4961726090
Websitehttps://www.freseniusmedicalcare.com/
BörsenkürzelFMS
IPO-datumOct 02, 1996
CEOCordola (Craig)

Führungskräfte von Fresenius Medical Care AG

Name
Name/Position
Position
Aktienbesitz
Veränderung
Ms. Pascale Witz
Ms. Pascale Witz
Independent Member of the Supervisory Board
Independent Member of the Supervisory Board
--
--
Dr. Dominik Heger
Dr. Dominik Heger
Head of Investor Relations, Strategic Development and Communications, EVP
Head of Investor Relations, Strategic Development and Communications, EVP
--
--
Ms. Helen Giza
Ms. Helen Giza
Chairman of the Management Board, Chief Executive Officer
Chairman of the Management Board, Chief Executive Officer
--
--
Mr. A. Gregory Sorensen, M.D.
Mr. A. Gregory Sorensen, M.D.
Independent Member of the Supervisory Board
Independent Member of the Supervisory Board
--
--
Mr. Martin Fischer
Mr. Martin Fischer
Chief Financial Officer, Member of the Management Board
Chief Financial Officer, Member of the Management Board
--
--
Mr. Michael Sen
Mr. Michael Sen
Chairman of the Supervisory Board
Chairman of the Supervisory Board
--
--
Ms. Sara Hennicken
Ms. Sara Hennicken
Member of the Supervisory Board
Member of the Supervisory Board
--
--
Mr. Shervin J. Korangy
Mr. Shervin J. Korangy
Independent Member of the Supervisory Board
Independent Member of the Supervisory Board
--
--
Dr. Marcus Kuhnert
Dr. Marcus Kuhnert
Independent Member of the Supervisory Board
Independent Member of the Supervisory Board
--
--
Ms. Stefanie Balling
Ms. Stefanie Balling
Vice Chairman of the Supervisory Board, Employee Representatives
Vice Chairman of the Supervisory Board, Employee Representatives
--
--
Mehr Anzeigen
Name
Name/Position
Position
Aktienbesitz
Veränderung
Ms. Pascale Witz
Ms. Pascale Witz
Independent Member of the Supervisory Board
Independent Member of the Supervisory Board
--
--
Dr. Dominik Heger
Dr. Dominik Heger
Head of Investor Relations, Strategic Development and Communications, EVP
Head of Investor Relations, Strategic Development and Communications, EVP
--
--
Ms. Helen Giza
Ms. Helen Giza
Chairman of the Management Board, Chief Executive Officer
Chairman of the Management Board, Chief Executive Officer
--
--
Mr. A. Gregory Sorensen, M.D.
Mr. A. Gregory Sorensen, M.D.
Independent Member of the Supervisory Board
Independent Member of the Supervisory Board
--
--
Mr. Martin Fischer
Mr. Martin Fischer
Chief Financial Officer, Member of the Management Board
Chief Financial Officer, Member of the Management Board
--
--
Mr. Michael Sen
Mr. Michael Sen
Chairman of the Supervisory Board
Chairman of the Supervisory Board
--
--

Häufig gestellte Fragen

Wer sind die fünf größten Anteilseigner von Fresenius Medical Care AG?

Die fünf größten Anteilseigner von Fresenius Medical Care AG sind: Ms. Pascale Witz

Wie viele Institutionen halten Anteile an Fresenius Medical Care AG (FMS)?

Mit Stand vom 2026Q1 halten 372 Institutionen Anteile an Fresenius Medical Care AG, mit einem Gesamtmarktwert von etwa 48.53M, was 8.98% der Gesamtanteile entspricht. Im Vergleich zum 2025Q4 ist der institutionelle Aktienbesitz um 134662.00 gestiegen.
tradingkey.logo
Risikohinweis: Unsere Website und mobile App bieten lediglich allgemeine Informationen zu bestimmten Anlageprodukten. Finsights stellt keine Finanzberatung oder Empfehlung für ein Anlageprodukt bereit, und die Bereitstellung solcher Informationen darf nicht als Finanzberatung durch Finsights ausgelegt werden.
Anlageprodukte unterliegen erheblichen Anlagerisiken, einschließlich des möglichen Verlusts des investierten Kapitals und sind möglicherweise nicht für jeden geeignet. Die vergangene Wertentwicklung von Anlageprodukten ist nicht unbedingt ein Hinweis auf deren zukünftige Wertentwicklung.
Finsights kann Drittanbietern oder Partnern erlauben, Werbung auf unserer Website oder in unserer mobilen App oder in Teilen davon zu platzieren oder bereitzustellen. Finsights kann für diese Anzeigenvergütung erhalten, basierend auf Ihrer Interaktion mit den Werbeanzeigen.
© Urheberrecht: FINSIGHTS MEDIA PTE. LTD. Alle Rechte vorbehalten.